Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
ABSTRACT Aim/Introduction Although immune checkpoint inhibitor‐related type 1 diabetes mellitus (ICI‐T1DM) is a rare condition, it is of significant concern globally. We aimed to elucidate the precise incidence, risk factors, and impact of ICI‐T1DM on survival outcomes. Materials and Methods The stu...
Saved in:
Main Authors: | Fumika Kamitani, Yuichi Nishioka, Miyuki Koizumi, Hiroki Nakajima, Yukako Kurematsu, Sadanori Okada, Shinichiro Kubo, Tomoya Myojin, Tatsuya Noda, Tomoaki Imamura, Yutaka Takahashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.14362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database.
by: Yoshiyuki Yokomaku, et al.
Published: (2025-01-01) -
Role of spindle assembly checkpoint proteins in gametogenesis and embryogenesis
by: Renju Pun, et al.
Published: (2025-01-01) -
Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
by: B.E. Nelson, et al.
Published: (2025-03-01) -
Resistance mechanisms to immune checkpoint inhibitors: updated insights
by: Besan H. Alsaafeen, et al.
Published: (2025-01-01) -
TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
by: Maria C. Arroyo López, et al.
Published: (2025-01-01)